Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-006369
Filing Date
2020-05-12
Accepted
2020-05-12 07:01:08
Documents
44
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q swtx-20200331x10q.htm 10-Q 1475180
2 EX-31.1 swtx-20200331ex311618533.htm EX-31.1 14315
3 EX-31.2 swtx-20200331ex312c253df.htm EX-31.2 14407
4 EX-32.1 swtx-20200331ex321a31eda.htm EX-32.1 8902
5 EX-32.2 swtx-20200331ex322eac706.htm EX-32.2 8976
  Complete submission text file 0001558370-20-006369.txt   2971069

Data Files

Seq Description Document Type Size
6 EX-101.INS swtx-20200331.xml EX-101.INS 228892
7 EX-101.SCH swtx-20200331.xsd EX-101.SCH 24075
8 EX-101.CAL swtx-20200331_cal.xml EX-101.CAL 28974
9 EX-101.DEF swtx-20200331_def.xml EX-101.DEF 64667
10 EX-101.LAB swtx-20200331_lab.xml EX-101.LAB 228522
11 EX-101.PRE swtx-20200331_pre.xml EX-101.PRE 154332
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39044 | Film No.: 20867016
SIC: 2836 Biological Products, (No Diagnostic Substances)